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Nasal polyps are a clinical sign of alert for investigating 
Cystic Fibrosis (CF). Aims: To study the incidence of nasal 
polyps in children and adolescents with cystic fibrosis, its 
possible association with age, gender, clinical manifestations, 
genotype and sweat chlorine level, and its evolution with 
topical steroid therapy. Methods: Clinical symptoms, sweat 
chlorine level and genotype were studied in 23 cystic fibrosis 
patients. Nasal polyps were diagnosed by nasal endoscopy 
and treated with topical steroids during 6 months, followed by 
a second nasal endoscopy. Fisher test was used for statistical 
analysis. Results: Nasal polyps were found in 39.1% of the 
patients (five bilateral, four unilateral), all older than six years, 
recurrent pneumonia in 82.6%, pancreatic insufficiency in 87% 
and malnutrition in 74%. No association was seen between 
nasal polyps and sweat chlorine level, genotype, clinical sings 
of severity and nasal symptoms. Seven patients improved in 
their nasal polyps with topical steroids, six showed complete 
resolution. Conclusion: The study showed a high incidence 
of nasal polyps in older children, who span the entire range 
of clinical severity, even in the absence of clinical nasal 
symptoms. Topical steroid therapy showed good results. 
An interaction among pediatricians and otolaryngologists is 
necessary for diagnosis and follow-up.
Keywords: diagnosis, endoscopy, cystic fibrosis, polyposis, 
therapy.
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INTRODUCTION
Cystic fibrosis (CF) is the most common lethal ge-
netic disease in Caucasians, of autosomal, recessive trans-
mission, at a rate of 1:2000 live births in this population1,2, 
in Brazil, the incidence is of 1:9500 in Paraná3, 1:8700 in 
Santa Catarina4 and 1:10.0005 in Minas Gerais.
The variable severity associated with the clinical 
manifestations (distinctive phenotypes) depends partially 
on the genotype and results from the obstructive pheno-
mena, thus characterizing the cystic fibrosis:
1. Chronic suppurative obstructive pulmonary 
disease;
2. Pancreatic insufficiency with digestion problems 
and malabsorption, resulting in secondary malnutrition;
3. Increased concentrations of chlorine and sodium, 
and age.
4. Adult male infertility.
Symptoms onset varies broadly, depending on mu-
tation type, homozygote patients for the genetic mutation 
F508 start having symptoms in the first 2-4 months of 
life. The classic clinical picture starts with dry cough, ta-
chypnea, mild intercostal pulling, or, it may manifest itself 
as acute infection, like bronchiolitis. The clinical course 
evolves with recurrent pneumonia. Together with all of 
this, the patient has difficulty gaining weight, despite a vo-
racious appetite, enlarged and more frequent foul-smelling 
defecation, diarrhea or steatorrhea (oily feces) 1,2.
Cystic fibrosis is diagnosed based on at least two 
of the four clinical-laboratorial aspects: family history of 
cystic fibrosis, pancreatic insufficiency, chronic suppu-
rative obstructive pulmonary disease and high levels of 
chlorine and sodium (>60mEq/l) in their sweat secretion. 
Other clinical data that suggest the diagnoses are: me-
conium ileum and/or intestinal obstruction with atresia, 
deficient weight-height development, heat stress, chronic 
pansinusitis, nasal polyps, volvus and intusception, and 
azoospermia6,7.
Clinical manifestations in the upper airways (UAW) 
happen to 100% of the patients, including recurrent sinu-
sitis, rhinitis and/or nasal polyposis8-11. The incidence of 
nasal polyps has been reported in 6 to 48% of the cases12,13, 
by the time cystic fibrosis is diagnosed, about 4% of the pa-
tients have some symptoms associated with nasal polyps. 
It is believed that about 14% of the patients with cystic 
fibrosis will require surgery to treat the polyps8,10,11,14.
Based on these data from the literature, the depart-
ments of pediatric pneumology and otorhinolaryngology 
of the Botucatu Medical School - UNESP, decided to assess 
UAW involvement in patients with cystic fibrosis in the 
outpatient ward. 
OBJECTIVE
The general goal of our paper was to assess nasal 
polyp incidence through endoscopy in children and ado-
lescents with cystic fibrosis being followed in the outpa-
tient ward. The specific goals were: 
1- to assess age, gender, clinical symptoms and the 
genetic mutation of these patients, and the association 
between these data and nasal polyposis;
2- assess polyposis evolution with topical steroi-
ds.
PATIENTS AND METHODS
The present contemporary cross-sectional and pros-
pective cohort was approved by the Ethics in Research 
Committee of the Botucatu Medical School - UNESP, under 
protocol # 1743/2005. The parents/guardians signed an 
Informed Consent Form. 
In 2005 we assessed the 23 patients being followed 
at the Cystic Fibrosis Reference Center Outpatient Ward, 
with ages ranging between 1 year and 9 months and 22 
years and 8 months.
From their charts, we obtained data related to gen-
der, age, clinical manifestations of CF such as meconium 
ileum, malnutrition, pancreatic insufficiency and repetition 
pneumonia, and laboratorial exams to confirm CF, such as 
quantitative analysis of ion content in sweat7 and genetic 
studies. All patients underwent otolaryngological evalua-
tion and suffered nasal endoscopy. During the consultation 
we obtained information related to nasal obstruction, oral 
breathing, asthma and sinusitis. 
Nasal endoscopy was carried out under topical 
anesthesia, using a flexible Storz pediatric bronchoscope 
of 2.4mm in diameter, or a rigid 30º, 2.4mm Storz scope.
In the nasal exam we described whether or not 
polyps were present, following the staging classification 
proposed by Johansson et al.15 (level 0 - absent, level 
I - polyp in the middle meatus, level II - polyp going 
through the middle turbinate with clear nasal floor, level 
III - polyp filling up the entire nasal cavity, whether or 
not there is secretion and its color, nasal mucosa aspect 
(color, edema, degeneration).
Those patients with nasal polyposis were prospecti-
vely followed up and submitted to clinical treatment with 
topical steroids in the habitual dose (mometasone 200 
mcg per day) for 6 months. After this period, the nasal 
endoscopic exam was repeated.
For statistical analysis, the data obtained were des-
cribed in their mean and standard deviation values. Age, 
gender, clinical symptoms and genetic mutations were 
associated with the presence of polyps. We used Fisher’s 
Exact Test, at a significance level of p<0.05.
RESULTS
The median age of the 23 patients was of six years 
and four months, and 20 of them were males.
18
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 74 (1) JANUARY/FEBRUARY 2008
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Most of the patients presented with the classical cli-
nical manifestations, and 82.6% had repetition pneumonia, 
87% had pancreatic insufficiency, 74% malnutrition and 
13%, meconium ileum. CF was confirmed in all of them, 
with too high chlorine levels in the sweat, the mean value 
was of 92.093 ± 24.625 mEq/l. Genetic mutations were 
investigated in all subjects. We found eight patients with 
F 508/other genetic mutation, three F 508/F508, one 
F508/G 542X, one G542X/other, one R1162X/R1162X 
and in nine patients we did not observe mutations.
As to respiratory complaints, 35% of the patients 
had asthma, 22% had frequent sinusitis - as diagnosed by 
pediatric pneumologists and 22% were diagnosed with 
oral breathing. 
Nasal endoscopy revealed nasal polyps in 39.1% 
(nine patients) of the patients. Of these, five patients had 
bilateral polyposis and four had unilateral disease, level 
I in four, level II in one patient and Level III in four pa-
tients (Figures 1 and 2). Nasal polyposis was diagnosed 
in children as of six years and three months of age, with 
incidence increase as age increased (Graph 1). There was 
no association between gender, age, clinical severity and 
genetic mutation with nasal polyposis.
level I polyps. One patient had his polyposis improve 
from level III to level II. Two patients with bilateral level 
III and another with unilateral level I did not show any 
improvement. One patient had level I unilateral polyp 
involution, however he later had a new level I polyp in 
the contralateral side - according to the endoscopic exam 
(Table I). 
DISCUSSION
The patients assessed during diagnosis had the 
classical cystic fibrosis clinical signs and symptoms, such 
as meconium ileum, pancreatic insufficiency, malnutrition 
and repetition pneumonia. Diagnostic confirmation was 
carried out based on two abnormal levels of chlorine ion 
in their sweat.
Sinusal disease, diagnosed by CT scan, has been 
reported in CF in up to 100% of the cases9,10,11,13,14, although 
the percentage of adult patients with clinical manifesta-
tion is much lower7,8,13. It is believed that the thick mucus 
reduces ciliary movement, causes meatal obstruction and 
both hypercapnia and hypoxia facilitate the development 
Figure 1. Endoscopic image of a grade III polyp in the right nasal cavity 
of patient #1. P - polyp S - nasal septum
After six months of clinical treatment with topical 
steroids in the habitual dose, we observed that of the 
nine children with polyps, seven (67.7%) improved. Six 
had complete polyp remission. Of these, in regards to the 
classification, two had bilateral level III polyposis, one 
had bilateral level II polyposis and three had unilateral 
Figure 2. Endoscopic image of a grade I nasal polyp in the right nasal 
cavity of patient # 7. - P - polyp CM - middle turbinate
Graph 1. Distribution of cystic fibrosis patients in relation to age and 
nasal polyps present.
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of local infection/inflammation. In the population studied 
we observed an incidence of sinusitis and oral breathing 
in 22% of the patients, and such incidence rates are similar 
to the ones reported by other authors9,10,13,19; however only 
one of these patients reported nasal polyps. Similar data 
were published in 2002 by Henriksson et al.13 in a study 
involving 111 patients with cystic fibrosis with median age 
of 18 years. During nasal endoscopic exam they observed 
nasal polyps in 39% of the patients; however they found 
no correlation between nasal obstruction, nasal secretion 
and polyps in these patients. 
In the literature, nasal polyposis has been reported 
at an incidence rate of 6 to 48% in patients with CF10,11,17, 
and a recent national study16 showed that children of a 
median age of 9.5 years had an incidence rate of 15.2%. 
In the present study, the incidence of nasal polyposis 
was similar to the one reported in the literature; however, 
consider the finding of 39.1% of children and adolescents 
with high levels of polyposis, because the aforementioned 
studies included adults in their series. When patients below 
10 years of age were assessed, the incidence reported was 
between 5 and 15.2%16,18. Schmitt et al.18 in 2005, assessing 
893 children with CF, found nasal polyps in only 5% of 
the children, and in 0.2% cystic fibrosis was diagnosed 
due to the presence of polyps. This is a very important 
piece of data, because although the isolated polyp does 
not always mean cystic fibrosis, the otolaryngologist must 
investigate it because of its severity and importance in 
early diagnosis and treatment in order to provide a better 
survival prognosis. 
In 1992, Ramsey et al.11 had already seen small 
polyps during endoscopic exam, unseen by anterior rhi-
noscopy. Similar to the study carried out by Henriksson 
et al.13, the polyps were classified as small in 68% of the 
patients; in 23% the polyps were in the meatus, being 
diagnosed only by means of nasal endoscopy. In our 
study, four (45%) patients had small polyps, stressing the 
importance of routine nasal endoscopy and clinician-oto-
laryngologist interaction. 
It is believed that up to 20% of the patients with 
nasal polyps require surgery8,9,11, and endoscopic surgery 
is the best approach8,20. According to Kingdom et al.14, 
the  F 508 genetic mutation is the most relevant in pa-
tients with CF and polyposis, requiring nasal surgery. In 
our study, we did not find any association between nasal 
polyp presence or severity and genotype.
Surgical recurrences are frequent, reported in up 
to 13% of the patients who undergo functional surgery. 
Thus, there are authors who suggest treatment with topi-
cal steroids as a routine approach to treat nasal polyps, 
resorting to surgery only in cases of failures21. In the group 
studied, topical steroids showed improvement in seven 
(77.7%) patients, of whom 85.7% had complete polyp 
involution. These results are better than the ones seen in 
the literature, showing polyposis improvement in 56% of 
the cases8. For the specific population of patients with 
cystic fibrosis there is no data about clinical treatment 
development in longer periods.
Table 1. Clinical manifestations in patients with cystic fibrosis and nasal polyps and its evolution with clinical treatment. 
Patient Age(m) Asthma Sinusitis
Oral 
Breathing
Genetic 
mutation
Polyposis and Treatment
Before After
01 103 No No No 
R1162X/
R1162X
Bilateral
Grade III
Bilateral
Grade III
02 102 Yes No No F508/? RightGrade I Absent
03 139 Yes No No ?/?
Left
Grade I
Left
Grade I
04 75 No No No G542X/?
Bilateral
Grade III
Absent
05 106 Yes Yes Yes ?/?
Bilateral
Grade III
Absent
06 139 No No No F508/? BilateralGrade III
Bilateral
Grade II
07 272 No No No ?/?
Right
Grade I
Right
Grade I
08 179 Yes No No ?/?
Bilateral
Grade III
Absent
09 164 Yes No No ?/?
Left
Grade I
Absent
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CONCLUSIONS
In the population studied, the incidence of nasal 
polyps was high (39.1%), and was diagnosed in children 
above six years of age. There was no association between 
nasal polyps and age, gender, genetic mutation, chlorine 
levels in sweat or clinical symptoms. Polyposis treatment 
with steroids proved efficacious in 77.7% of the patients. 
FINAL REMARKS
Nasal polyps in patients with cystic fibrosis are 
common, even in the pediatric population, unrelated with 
nasal symptoms. Its diagnosis must be endoscopic. It is 
fundamental to have pediatric pneumologists working 
closely with otolaryngologists for better diagnosis and 
follow up. 
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